SB 271 VA To Executive
Prescription Drug Affordability Board; established.
A state bill is a proposed law in a state legislature — separate from the U.S. Congress. Learn more →
Summary
Prescription Drug Affordability Advisory Panel established; maximum fair price; annual reports; civil penalties. Directs the Secretary of Health and Human Resources to establish the Prescription Drug Affordability Advisory Panel to conduct data analyses, develop policy recommendations, and identify implementation barriers related to strategies to improve prescription drug affordability, enhance price transparency, and strengthen data collection practices for prescription drugs across public and private payers. The bill requires the Panel to (i) report annually on prescription drug pricing trends and any policy recommendations on legislation to improve prescription drug affordability and (ii) provide quarterly updates on prescription drug pricing trends. The bill requires each pharmacy benefits manager to provide to the Panel, upon request, certain information relating to the dispensation of a referenced drug, as defined in the bill.The bill prohibits prescription drug manufacturers or wholesale distributors permitted or licensed in the Commonwealth from accepting payment at an amount higher than the maximum fair price established by the U.S. Secretary of Health and Human Services pursuant to federal law for the sale of a referenced drug intended for use by individuals in the Commonwealth. Under the bill, an entity that violates such prohibition is subject to a civil penalty of $10,000 per violation. The bill also prohibits a manufacturer subject to its provisions from removing a referenced drug from sale distribution in the Commonwealth for the purpose of avoiding the impact of the bill's rate limitations without providing certain prior notice. Under the bill, a manufacturer that violates such prohibition on removing a referenced drug without the required notice is subject to a civil penalty equal to the greater of $100,000 or the total amount of annual savings for the referenced drug, as determined by the Board of Pharmacy. This bill is identical to HB 483.
Sponsor (1)
- R. Creigh Deeds Democratic · primary
1 coauthor / cosponsor
- Jennifer D. Carroll Foy Democratic · cosponsor
Action history (45)
- Jan 12, 2026 Prefiled and ordered printed; Offered 01-14-2026 26105318D · upper
- Jan 12, 2026 Referred to Committee on Education and Health · upper
- Jan 22, 2026 Rereferred from Education and Health to Commerce and Labor (14-Y 0-N) · upper
- Jan 26, 2026 Senate committee offered · upper
- Jan 26, 2026 Reported from Commerce and Labor with amendments and rereferred to Finance and Appropriations (10-Y 4-N 1-A) · upper
- Jan 27, 2026 Fiscal Impact Statement from Department of Planning and Budget (SB271) · upper
- Feb 3, 2026 Reported from Finance and Appropriations (9-Y 5-N 1-A) · upper
- Feb 4, 2026 Rules suspended · upper
- Feb 4, 2026 Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A) · upper
- Feb 4, 2026 Passed by for the day Block Vote (Voice Vote) · upper
- Feb 5, 2026 Read second time · upper
- Feb 5, 2026 Commerce and Labor Amendments agreed to · upper
- Feb 5, 2026 Engrossed by Senate as amended (Voice Vote) · upper
- Feb 6, 2026 Read third time and passed Senate (31-Y 8-N 0-A) · upper
- Feb 10, 2026 Fiscal Impact Statement from Department of Planning and Budget (SB271) · upper
- Feb 11, 2026 Assigned HAPP sub: Health & Human Resources · lower
- Feb 12, 2026 Placed on Calendar · lower
- Feb 12, 2026 Read first time · lower
- Feb 12, 2026 Referred to Committee on Appropriations · lower
- Mar 4, 2026 Reported from Appropriations (17-Y 5-N) · lower
- Mar 6, 2026 Read second time · lower
- Mar 9, 2026 Floor substitute printed 26109393D-H1 (Delaney) · lower
- Mar 9, 2026 Floor offered Delegate Delaney Substitute · lower
- Mar 9, 2026 Floor offered Delegate Delaney Amendments · lower
- Mar 9, 2026 Read third time · lower
- Mar 9, 2026 Passed by temporarily · lower
- Mar 9, 2026 Passed by for the day · lower
- Mar 10, 2026 Floor substitute printed 26109555D-H2 (Delaney) · lower
- Mar 10, 2026 Floor offered Delegate Delaney Substitute · lower
- Mar 10, 2026 Read third time · lower
- Mar 10, 2026 Delegate Delaney Substitute withdrawn by House · lower
- Mar 10, 2026 Delegate Delaney Floor amendments withdrawn · lower
- Mar 10, 2026 Delegate Delaney Floor substitute agreed to · lower
- Mar 10, 2026 Engrossed by House - floor substitute · lower
- Mar 10, 2026 Passed House with substitute (95-Y 4-N 0-A) · lower
- Mar 11, 2026 House substitute agreed to by Senate · upper
- Mar 23, 2026 Fiscal Impact Statement from Department of Planning and Budget (SB271) · upper
- Mar 30, 2026 Enrolled · upper
- Mar 30, 2026 Bill text as passed Senate and House (SB271ER) · upper
- Mar 30, 2026 Signed by President · upper
- Mar 31, 2026 Fiscal Impact Statement from Department of Planning and Budget (SB271) · upper
- Mar 31, 2026 Signed by Speaker · lower
- Mar 31, 2026 Enrolled Bill communicated to Governor on March 31, 2026 · upper
- Mar 31, 2026 Governor's Action Deadline 11:59 p.m., April 13, 2026 · executive
- Apr 13, 2026 Governor's recommendation received by Senate · executive
Text versions (16)
The published texts of this bill as it moves through the legislature. Each links to the official document on the state legislature site. Data from OpenStates.
- Governor Substitute · PDF
- Governor Substitute · HTML
- Governor's Recommendation · HTML
- Enrolled · PDF
- Enrolled · HTML
- Delegate Delaney Substitute · PDF
- Delegate Delaney Substitute · HTML
- Delegate Delaney Substitute · PDF
- Delegate Delaney Substitute · HTML
- Delegate Delaney Amendments · HTML
- Engrossed · PDF
- Engrossed · HTML
- Commerce and Labor Amendment · HTML
- Commerce and Labor Amendment · HTML
- Introduced · PDF
- Introduced · HTML
Full text
The full text hasn’t been imported yet. CivicGate fetches it from the state legislature’s published version documents — check now.
Comments
Data from OpenStates. View on OpenStates →
Comments